Evaxion A (EVAX) Short term Debt (2021 - 2025)
Evaxion A (EVAX) reported Short term Debt of $190000.0 for Q4 2025, up 19.5% on a YoY basis from $159000.0 in Q4 2024, and up 3.26% quarter-over-quarter from $184000.0 in Q2 2025.
Evaxion A (EVAX) Short term Debt (2021 - 2025) Analysis & Trends
Evaxion A has reported Short term Debt for 5 years, with the latest figure at $190000.0 in Q4 2025.
- For the quarter ending Q4 2025, Short term Debt rose 19.5% year-over-year to $190000.0; the trailing twelve-month figure through Dec 2025 stood at $190000.0 (up 19.5% YoY), and the FY2025 full-year result was $190000.0, up 19.5% from the prior year.
- Short term Debt for Q4 2025 stood at $190000.0, up from $184000.0 in the prior quarter.
- The five-year high for Short term Debt was $190000.0 in Q4 2025, with the low at $119000.0 in Q2 2022.
- Historically, Short term Debt has averaged $151545.5 across 5 years, with a median of $158000.0 in 2024.
- Annual changes were most pronounced in 2023 — Short term Debt rose 27.73% — and 2024, when it changed 0.0%.
- Evaxion A's Short term Debt stood at $126000.0 in 2021, then rose by 7.94% to $136000.0 in 2022, then gained by 16.91% to $159000.0 in 2023, then changed by 0.0% to $159000.0 in 2024, then rose by 19.5% to $190000.0 in 2025.
- The last three Short term Debt figures came in at $190000.0 (Q4 2025), $184000.0 (Q2 2025), and $159000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 190,000.00 |
| Jun 30, 2025 | 184,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Dec 31, 2023 | 159,000.00 |
| Jun 30, 2023 | 152,000.00 |
| Dec 31, 2022 | 136,000.00 |
| Jun 30, 2022 | 119,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 126,000.00 |
| Sep 30, 2021 | 159,000.00 |